Julia Reichel, BA
Although clinicians have long preferred IV tranexamic acid (TXA) to its oral counterpart in joint arthroplasties for ease of use and consistent results, little research has compared the approaches.
Now, a group of investigators from the Hospital for Special Surgery has started down that road, with interim results demonstrating that oral TXA is not inferior to the IV formulation for both total knee and total hip arthroplasty procedures.
“While guidelines suggest that all